Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 181 | COGT | COGENT BIOSCIENCES INC | Healthcare | 6,476.0 | $249K | 0.07% | +159.0 | +2.5% | $38.49 | -11.2% |
| 182 | JANX | JANUX THERAPEUTICS INC | Healthcare | 17,821.0 | $248K | 0.07% | +433.0 | +2.5% | $13.90 | +3.5% |
| 183 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 7,354.0 | $239K | 0.07% | +180.0 | +2.5% | $32.54 | -2.6% |
| 184 | BEAM | BEAM THERAPEUTICS INC | Healthcare | 9,966.0 | $237K | 0.07% | +242.0 | +2.5% | $23.83 | +17.2% |
| 185 | — | NEWAMSTERDAM PHARMA COMPANY | — | 7,319.0 | $234K | 0.07% | +177.0 | +2.5% | $32.01 | — |
| 186 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 25,154.0 | $234K | 0.07% | +613.0 | +2.5% | $9.31 | +5.4% |
| 187 | PRME | PRIME MEDICINE INC | Healthcare | 66,508.0 | $231K | 0.06% | +2K | +2.5% | $3.48 | -10.1% |
| 188 | — | INHIBRX BIOSCIENCES INC | — | 3,425.0 | $230K | 0.06% | +82.0 | +2.5% | $67.23 | — |
| 189 | ARVN | ARVINAS INC | Healthcare | 21,676.0 | $230K | 0.06% | +528.0 | +2.5% | $10.60 | -14.3% |
| 190 | QURE | UNIQURE NV | Healthcare | 13,977.0 | $229K | 0.06% | +341.0 | +2.5% | $16.35 | +69.7% |
| 191 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 40,457.0 | $224K | 0.06% | +986.0 | +2.5% | $5.53 | +87.5% |
| 192 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 14,299.0 | $222K | 0.06% | +350.0 | +2.5% | $15.50 | +3.2% |
| 193 | PROK | PROKIDNEY CORP | Healthcare | 123,388.0 | $221K | 0.06% | +3K | +2.5% | $1.79 | -4.5% |
| 194 | XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | 38,030.0 | $221K | 0.06% | +928.0 | +2.5% | $5.80 | +10.0% |
| 195 | VERA | VERA THERAPEUTICS INC | Healthcare | 5,474.0 | $220K | 0.06% | +132.0 | +2.5% | $40.23 | -1.7% |
| 196 | EYPT | EYEPOINT INC | Healthcare | 17,052.0 | $220K | 0.06% | +414.0 | +2.5% | $12.89 | +2.7% |
| 197 | SVRA | SAVARA INC | Healthcare | 39,405.0 | $215K | 0.06% | +962.0 | +2.5% | $5.46 | -3.5% |
| 198 | — | ANGLOGOLD ASHANTI PLC | — | 2,199.0 | $214K | 0.06% | +392.0 | +21.7% | $97.36 | — |
| 199 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 47,095.0 | $211K | 0.06% | +1K | +2.5% | $4.47 | +40.9% |
| 200 | — | ASSEMBLY BIOSCIENCES INC | — | 7,553.0 | $210K | 0.06% | +184.0 | +2.5% | $27.75 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
30.6%
Financial Services
23.4%
Industrials
11.2%
Technology
10.7%
Consumer Cyclical
7.6%
Energy
3.4%
Basic Materials
3.4%
Communication Services
3.1%
Consumer Defensive
2.9%
Real Estate
2.2%